ClinicalTrials.Veeva

Menu

Non-Interventional Consecutive and Prospective Study of e.Motion® PS Pro Prosthesis in the Total Knee Artroplasty

B. Braun logo

B. Braun

Status

Enrolling

Conditions

Knee Arthroplasty

Treatments

Device: Total Knee prothesis e motion PS Pro

Study type

Observational

Funder types

Industry

Identifiers

NCT02934802
AAG-O-H-1420

Details and patient eligibility

About

This post-market clinical follow-up study intends to investigate the survival rate at 5 years of the e.motion® PS Pro System.

Enrollment

140 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient having signed informed consent
  • Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided
  • Patients willing to participate in a 5 years follow-up

Exclusion criteria

  • Active or suspected infection
  • Tumor on the concerned knee
  • Patient vulnerable and under legal protection

Trial contacts and locations

1

Loading...

Central trial contact

Boubker Zniber; François Boillot

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems